Partnerships Lead to Medical Patents: An Intercampus Research Team Steers Scientific Progress on Biomaterials for Human Body Repair and Healing

By Wojcikowski, Jennifer | Human Ecology, Spring 2011 | Go to article overview

Partnerships Lead to Medical Patents: An Intercampus Research Team Steers Scientific Progress on Biomaterials for Human Body Repair and Healing


Wojcikowski, Jennifer, Human Ecology


Sixty-three U.S. and international patents for pseudo-protein biomaterials have emerged from the Ithaca lab of C. C. Chu, the Rebecca Q. Morgan '60 Professor of Fiber Science and Apparel Design in the College of Human Ecology--just in the past decade. With more patents pending and extensive partnerships with doctors and researchers at Weill Cornell Medical College (WCMC) in New York City, Chu continues to expand the use of biomaterial properties and practicalities in the treatment of wounds, diseased heart valves and blood vessels, bone repair, gene transfection for gene therapy, immunotherapy for cancer patients, and allergy treatment.

The collaborations are helping to bridge the gap between research and medical practice, enabling WCMC doctors to imagine new possibilities for treatment and Chu to test potential uses for his discoveries.

"Each generation of these products offers new applications and better performance than previous ones," said Chu, one of the founding members of the Biomedical Engineering Program at Cornell. "In my tribe [Chu's term for his lab] we are never standing still."

A key driver of Chu's continued progress is Cornell's commitment to fostering and funding working partnerships among researchers, especially within biomedical engineering, nanomedicine, and systems biology; diagnostics and experimental therapeutics; global health and infectious diseases; and cancer-related cell biology. These collaborations leverage Human Ecology and WCMC expertise and resources to advance research and development beyond what the traditional "silo" approach can yield.

"Although difficult to coordinate at times," said Bo Liu, a specialist in vascular disease, "these working relationships provide researchers access to clinical testing, making their discoveries much more translational."

Vascular grafts deliver drugs

Chu has partnered with Liu to create drug-eluting, biodegradable vascular grafts. Their research is supported by the Morgan Seed Grants for Collaborative Multidisciplinary Research in Tissue Engineering. Liu's lab provided a clinical outlet for Chu's biomaterial research, advancing it from traditional material study to small animal testing, a critical first step in the long journey from basic research to clinical practice. The data collected by Liu, now an associate professor at the University of Wisconsin, have helped Chu to significantly advance the performance of biomaterials for cardiovascular treatment.

Vascular grafts have been commercially available for more than 50 years. While effective, these grafts are made of traditional fabrics such as polyesters and Gore-Tex that are non-biodegradable and offer no drug-eluting capabilities. Chu's vascular grafts, on the other hand, consist of patented amino-acid-based polyester amides (PEA) biomaterials invented in Chu's lab that are capable of delivering a wide range of bioactive compounds, such as nitric oxide.

Chu said the advantage to human cardiovascular health is that his grafts "biomimic" what the natural blood vessel already does. "Using nitric oxide for the vascular grafts was a natural choice because it is indigenous to the body," said Chu. "When stimulated, the body produces nitric oxide to dilate the blood vessels along with a host of other critical biological functions, helping to keep them open for optimal blood flow."

When rat aortic patches were tested in Liu's lab, the nitric oxide-eluting vascular grafts showed significant advantages over non-eluting grafts, including the ability to promote endothelial cell lining, protect against intimal hyperplasia (the thickening of the vessel wall), and mute inflammation.

The Chu lab's PEA-based biomaterials offer another advantage, thanks to an unusual and unique biological property: muted inflammatory response to foreign bodies. It's a trait that is unmatched by current FDA-approved biomaterials and their medical devices, Chu said. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Partnerships Lead to Medical Patents: An Intercampus Research Team Steers Scientific Progress on Biomaterials for Human Body Repair and Healing
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.